(Q34807255)

4 August 2017

1 reference

title

Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy (English)

1 reference

4 August 2017

1 reference

1 reference

Peter Borowski

1

1 reference

PubMed ID

12206878

4 August 2017

Sarah Schalinski

series ordinal

2

1 reference

PubMed ID

12206878

4 August 2017

Herbert Schmitz

series ordinal

3

1 reference

4 August 2017

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

55

1 reference

4 August 2017

397-412

1 reference

4 August 2017

3

1 reference

Specific Interaction of Hepatitis C Virus Protease/Helicase NS3 with the 3'-Terminal Sequences of Viral Positive- and Negative-Strand RNA

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Candidate targets for hepatitis C virus-specific antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Secondary structure determination of the conserved 98-base sequence at the 3' terminus of hepatitis C virus genome RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Non-structural protein 3 of hepatitis C virus inhibits phosphorylation mediated by cAMP-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Characterisation of non-structural protein 3 of hepatitis C virus as modulator of protein phosphorylation mediated by PKA and PKC: evidences for action on the level of substrate and enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Biochemical properties of a minimal functional domain with ATP-binding activity of the NTPase/helicase of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Identification and characterization of a histone binding site of the non-structural protein 3 of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Purification and Characterization of West Nile Virus Nucleoside Triphosphatase (NTPase)/Helicase: Evidence for Dissociation of the NTPase and Helicase Activities of the Enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Characterization of imidazo[4,5-d]pyridazine nucleosides as modulators of unwinding reaction mediated by West Nile virus nucleoside triphosphatase/helicase: evidence for activity on the level of substrate and/or enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Single-stranded DNA binding proteins required for DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Synthesis of 1-(2'--Methyl--D-ribofuranosyl)-1-imidazo[4,5-]pyridazine-4,7(5,6)-dione: An Attractive Building Block for Antisense and Triple-helical Applications ‡

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Crystal structure of RNA helicase from genotype 1b hepatitis C virus. A feasible mechanism of unwinding duplex RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Review: molecular biology of the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

RNA helicases: modulators of RNA structure

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Effect of the calmodulin inhibitor trifluoperazine on phosphorylation of P-glycoprotein and topoisomerase II: relationship to modulation of subcellular distribution, DNA damage and cytotoxicity of doxorubicin in multidrug resistant L1210 mouse leuke

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

DNA unwinding activity of replication protein A

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Viral proteins containing the purine NTP-binding sequence pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Helicases: amino acid sequence comparisons and structure-function relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

The RNA helicase and nucleotide triphosphatase activities of the bovine viral diarrhea virus NS3 protein are essential for viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Characterization of RNA binding activity and RNA helicase activity of the hepatitis C virus NS3 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

A protein component of Drosophila polar granules is encoded by vasa and has extensive sequence similarity to ATP-dependent helicases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Probing the relationship between RNA-stimulated ATPase and helicase activities of HCV NS3 using 2'-O-methyl RNA substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Ribavirin therapy for Hantaan virus infection in suckling mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

The 3'-untranslated region of hepatitis C virus RNA enhances translation from an internal ribosomal entry site

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Towards defining a minimal functional domain for NTPase and RNA helicase activities of the hepatitis C virus NS3 protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Homologous potyvirus and flavivirus proteins belonging to a superfamily of helicase-like proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

The helicase from hepatitis C virus is active as an oligomer

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

The protein family of RNA helicases

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Antihelicase action of CI-958, a new drug for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

1 reference

7 January 2021

Mutagenesis of the Dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Lassa fever. Effective therapy with ribavirin

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Molecular evolution of hepatitis viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Biological evaluation of hepatitis C virus helicase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Pestivirus translation initiation occurs by internal ribosome entry

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Strand-separating activity of hepatitis C virus helicase in the absence of ATP.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

A steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus-encoded glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Interferon therapy for acute hepatitis C viral infection--a review by meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Internal processing of hepatitis C virus NS3 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3)

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

RNA-stimulated NTPase activity associated with the p80 protein of the pestivirus bovine viral diarrhea virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Internal ribosome entry site within hepatitis C virus RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Pestivirus NS3 (p80) protein possesses RNA helicase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Alive with DEAD proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Identification of the domains of photoincorporation of the 3'- and 7-benzophenone analogues of taxol in the carboxyl-terminal half of murine mdr1b P-glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Structure of the hepatitis C virus RNA helicase domain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Nucleoside triphosphatase and RNA helicase activities associated with GB virus B nonstructural protein 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Adriamycin inhibits human RH II/Gu RNA helicase activity by binding to its substrate.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

Ribavirin monotherapy in patients with chronic hepatitis C: a retrospective study of 95 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900096-7

7 January 2021

10.1016/S0166-3542(02)00096-7

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12206878